Wright Medical Technology, Inc., commonly referred to as Wright Medical, is a prominent player in the orthopaedic and biologics industry, headquartered in the United States. Founded in 1950, the company has established itself as a leader in innovative solutions for extremities and biologics, focusing on products that enhance patient outcomes in surgical procedures. With a strong presence in North America and expanding operations in Europe and Asia, Wright Medical offers a diverse range of core products, including advanced implants and surgical instruments designed for foot, ankle, and upper extremity surgeries. Their commitment to research and development has led to notable achievements, positioning them as a trusted partner for healthcare professionals. Wright Medical's unique approach to product design and patient care continues to set them apart in a competitive market.
How does Wright Medical Technology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Wright Medical Technology, Inc.'s score of 34 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wright Medical Technology, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. As a current subsidiary of Stryker Corporation, any climate commitments or emissions data would be inherited from Stryker. Stryker Corporation has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which are cascaded to Wright Medical Technology. However, specific reduction targets or achievements for Wright Medical Technology are not detailed. The absence of direct emissions data highlights the need for further transparency in Wright Medical Technology's climate commitments. As part of the broader corporate family, the company is expected to align with Stryker's sustainability goals, which may include significant reductions in Scope 1, 2, and 3 emissions in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 27,076,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 146,705,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Wright Medical Technology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.